您当前的位置:
首页 >
文章列表页 >
Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site
Full-length article | 更新时间:2023-05-16
    • Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site

    • Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site

    • Genes & Diseases   2023年10卷第2期
    • 作者机构:

      1. Departments of Orthopaedic Surgery and Urology, The First Affiliated Hospital of Chongqing Medical University,Chongqing,China,400016

      2. School of Biomedical Engineering, Vanderbilt University,TN,Nashville,USA,37235

      3. Department of Clinical Laboratory Medicine, Shanghai Jiaotong University School of Medicine,Shanghai,China,200000

      4. Laboratory of Craniofacial Suture Biology and Development, Department of Surgery Section of Plastic Surgery, The University of Chicago Medical Center,IL,Chicago,USA,60637

      5. Molecular Oncology Laboratory, Department of Orthopedic Surgery and Rehabilitation Medicine, The University of Chicago Medical Center,IL,Chicago,USA,60637

    • DOI:10.1016/j.gendis.2022.09.001    

      中图分类号:
    • 纸质出版日期:2023,

      网络出版日期:2023-3-1,

    扫 描 看 全 文

  • Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site[J]. Genes & Diseases, 2023,10(2). DOI: 10.1016/j.gendis.2022.09.001.

    Zander Schwartz, Piao Zhao, Annie Wang, et al. Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site[J]. Genes & Diseases, 2023,10(2). DOI: 10.1016/j.gendis.2022.09.001.

  •  
  •  
查看原文

0

浏览量

0

下载量

0

CSCD

文章被引用时,请邮件提醒。
提交
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

暂无数据

相关作者

暂无数据

相关机构

暂无数据
0